Skip to main content
. 2012 Mar 29;5(3):240–243. doi: 10.1093/ckj/sfs031

Table 1.

Laboratory parameters before and after tumour removala

Time (hour:minute) Phosphate (mmol/L) Calcium (mmol/L) BiPTH (pg/mL) FGF23 (pg/mL) 1,25-vitD (pg/mL) 24,25-vitD (ng/mL) FE-Pi % FE-Ca %
Normal range: 0.80–1.50 2.15–2.50 5.5–30.9 10–50 20–80 5–15 1–2
0 0.87 2.32 46.4 71.3 88.5 5.6 32 0.59
0:35 ND ND 27.3 38.9 74.8 4.3
1:45 0.72 2.30 30 34.8 80.8 5.2
3:05 0.79 2.29 ND 31.7 76.2 5.2
4:05 ND ND ND 31 74.6 5
5:20 ND ND 35.5 29 90.2 6.2
6:15 0.75 2.21 ND 28 75.2 5.2
10:15 ND ND 40.9 28 95.2 4.5
14:20 0.79 2.37 ND 28 122.2 5.5
18:20 ND ND ND 28 134 5
22:20 0.81 2.37 ND 29 162.3 3.9
48 0.80 ND 56.4 ND ND ND 16 0.69
1 week 1.36 2.37 21.8 28 267 3.1
2 weeks 1.36 2.34 38.2 28 211.4 2.8
6 months 1.34 2.48 10.9 27 159.1 5.5
a

BiPTH, bioactive 1-84 parathyroid hormone; ND, not determined; 1,25 vit D, 1,25-dihydroxyvitamin D; 24,25-vitD, 24,25-dihydroxyvitamin D; FE-Pi and FE-Ca are fractional excretion of phosphate and calcium, respectively, and are calculated as [serum mineral × urine creatinine (mmol/L)/serum creatinine × urine mineral (mmol/L)]. To convert phosphate to mg/dL multiply with 3.1; calcium to mg/dL multiply with 4; BiPTH to pmol/L multiply with 0.9; 1,25 vit to pmol/L multiply with 2.496; 24,25 vit D to nmol/L multiply with 2.496.